Fujifilm will buy Cellular Dynamics International (CDI) for $307m to add induced stem cells to its offering and further build in regenerative medicines.
The deal - which will see Fujifilm pay $307m (€285m) in cash for the Wisconsin-headquartered cell producer - is expected to complete before the end of June.
CDI supplies induced pluripotent stem cells (iPSCs) to drugmakers for candidate screening and safety and efficacy testing. The US firm operates facilities in Madison, Wisconsin and Novato, California and employs 155 staff.
The planned takeover follows just months after Fujifilm acquired a majority stake in Japan Tissue Engineering (JTE), a regenerative medicine-focused developer. The earlier acquisition was acknowledged as a driver by CEO Shigetaka Komorisaid.